FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005698849> ?p ?o ?g. }

• W2005698849 endingPage "906" @default.
• W2005698849 startingPage "895" @default.
• W2005698849 abstract "Clonogenic immortalised human pre-osteoblastic cell lines provide useful species-specific experimental tools for the study of the regulation of osteoblastic proliferation and differentiation. Steroid hormones are major regulators of bone formation. Although much is known about the effects of dexamethasone on osteoblastic growth and differentiation in vitro, there is less information on the effects of trans-retinoic acid (RA), particularly in human cultures. We have established a clonal adult human cell line (C1) derived from a bone marrow aspirate. The cell line appeared to be bi-potential. The cells were able to differentiate into an adipocytic phenotype under appropriate culture conditions. When grown in osteogenic medium, the cells expressed alkaline phosphatase (ALP) and osteocalcin mRNA. The C1 cells also expressed several other osteoblastic markers such as collagen type 1 (COL 1), PTH/PTH-rp receptor constitutively. Transcripts for the osteoblast transcription factor Cbfa1 was also detected under basal conditions. In addition treatment with 1,25(OH)(2)D(3) (10(-7)M) led to a marked increase in osteocalcin mRNA expression suggesting that this cell line represents a pre-osteoblastic population. We compared the effects of Dex and RA on osteoblastic function. For the assessment of PTH/PTH-rp receptor, osteocalcin and Cbfa1 mRNA expression and PTH-stimulated adenylate cyclase responsiveness, the cells were grown in the presence of Dex and RA and harvested on Days 1, 3, 7 and 14. RA (10(-7)M) had a mitogenic effect on the C1 cells. In contrast, Dex (10(-7)M) inhibited proliferation. A similar effect was observed with primary human bone marrow stromal cultures. Both Dex and RA inhibited COL 1 synthesis and decreased COL1 mRNA. Dex stimulated ALP activity and increased ALP mRNA expression whilst RA had an inhibitory effect. Dex treatment led to an increase in PTH/PTH-rp receptor mRNA and PTH-induced cAMP accumulation with a peak response at 24 h and this effect was sustained for up to 14 days. In contrast, long-term culture with RA resulted in a reduction in the cAMP response to PTH (Days 7 and 14) with no effect on PTH/PTH-rp receptor mRNA expression. Osteocalcin and Cbfa1 mRNA expression did not alter in the presence of Dex and RA at these time points. This study shows that Dex and RA have differential effects on the expression of the phenotypic markers and genes associated with osteoblast maturation. This homogeneous cell line can therefore be used further to elucidate the cellular and molecular mechanisms of action of Dex and RA at the different developmental stages of human osteoblastic differentiation. This cell line may thus provide a useful species-specific in vitro model for the evaluation of key genes and signalling molecules involved in osteogenesis. This would be of help in the design of 'in vivo' studies." @default.
• W2005698849 created "2016-06-24" @default.
• W2005698849 creator A5000844351 @default.
• W2005698849 creator A5001000063 @default.
• W2005698849 creator A5022472685 @default.
• W2005698849 creator A5025493503 @default.
• W2005698849 creator A5026156054 @default.
• W2005698849 date "2002-10-01" @default.
• W2005698849 modified "2023-09-26" @default.
• W2005698849 title "Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics" @default.
• W2005698849 cites W1512497104 @default.
• W2005698849 cites W1964648879 @default.
• W2005698849 cites W1965174761 @default.
• W2005698849 cites W1969108838 @default.
• W2005698849 cites W1970530378 @default.
• W2005698849 cites W1987577354 @default.
• W2005698849 cites W1989572590 @default.
• W2005698849 cites W1992776027 @default.
• W2005698849 cites W1993876072 @default.
• W2005698849 cites W1999601565 @default.
• W2005698849 cites W2002773456 @default.
• W2005698849 cites W2016339350 @default.
• W2005698849 cites W2025146892 @default.
• W2005698849 cites W2028689130 @default.
• W2005698849 cites W2035000923 @default.
• W2005698849 cites W2038571131 @default.
• W2005698849 cites W2038783391 @default.
• W2005698849 cites W2039665575 @default.
• W2005698849 cites W2040845651 @default.
• W2005698849 cites W2053503690 @default.
• W2005698849 cites W2057254334 @default.
• W2005698849 cites W2058501242 @default.
• W2005698849 cites W2062076773 @default.
• W2005698849 cites W2075529268 @default.
• W2005698849 cites W2086722866 @default.
• W2005698849 cites W2100837269 @default.
• W2005698849 cites W2118549170 @default.
• W2005698849 cites W2155629196 @default.
• W2005698849 cites W2344080073 @default.
• W2005698849 cites W4235184440 @default.
• W2005698849 cites W4237968065 @default.
• W2005698849 cites W4239686916 @default.
• W2005698849 cites W4240768237 @default.
• W2005698849 cites W4241255713 @default.
• W2005698849 cites W4251504254 @default.
• W2005698849 cites W4253210820 @default.
• W2005698849 cites W4293247451 @default.
• W2005698849 cites W4294216491 @default.
• W2005698849 cites W4298135253 @default.
• W2005698849 doi "https://doi.org/10.1016/s0039-128x(02)00054-5" @default.
• W2005698849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12234625" @default.
• W2005698849 hasPublicationYear "2002" @default.
• W2005698849 type Work @default.
• W2005698849 sameAs 2005698849 @default.
• W2005698849 citedByCount "63" @default.
• W2005698849 countsByYear W20056988492012 @default.
• W2005698849 countsByYear W20056988492013 @default.
• W2005698849 countsByYear W20056988492014 @default.
• W2005698849 countsByYear W20056988492015 @default.
• W2005698849 countsByYear W20056988492016 @default.
• W2005698849 countsByYear W20056988492018 @default.
• W2005698849 countsByYear W20056988492019 @default.
• W2005698849 countsByYear W20056988492020 @default.
• W2005698849 crossrefType "journal-article" @default.
• W2005698849 hasAuthorship W2005698849A5000844351 @default.
• W2005698849 hasAuthorship W2005698849A5001000063 @default.
• W2005698849 hasAuthorship W2005698849A5022472685 @default.
• W2005698849 hasAuthorship W2005698849A5025493503 @default.
• W2005698849 hasAuthorship W2005698849A5026156054 @default.
• W2005698849 hasConcept C104317684 @default.
• W2005698849 hasConcept C126322002 @default.
• W2005698849 hasConcept C131075544 @default.
• W2005698849 hasConcept C134018914 @default.
• W2005698849 hasConcept C148738053 @default.
• W2005698849 hasConcept C160160445 @default.
• W2005698849 hasConcept C16930146 @default.
• W2005698849 hasConcept C181199279 @default.
• W2005698849 hasConcept C185592680 @default.
• W2005698849 hasConcept C202751555 @default.
• W2005698849 hasConcept C2778260815 @default.
• W2005698849 hasConcept C2780007613 @default.
• W2005698849 hasConcept C2781121885 @default.
• W2005698849 hasConcept C2908647359 @default.
• W2005698849 hasConcept C54355233 @default.
• W2005698849 hasConcept C55493867 @default.
• W2005698849 hasConcept C71924100 @default.
• W2005698849 hasConcept C81885089 @default.
• W2005698849 hasConcept C86803240 @default.
• W2005698849 hasConcept C99454951 @default.
• W2005698849 hasConceptScore W2005698849C104317684 @default.
• W2005698849 hasConceptScore W2005698849C126322002 @default.
• W2005698849 hasConceptScore W2005698849C131075544 @default.
• W2005698849 hasConceptScore W2005698849C134018914 @default.
• W2005698849 hasConceptScore W2005698849C148738053 @default.
• W2005698849 hasConceptScore W2005698849C160160445 @default.
• W2005698849 hasConceptScore W2005698849C16930146 @default.
• W2005698849 hasConceptScore W2005698849C181199279 @default.
• W2005698849 hasConceptScore W2005698849C185592680 @default.

• next